BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Lovastatin

A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.

300+ PubMed studies analyzed · 31 RCTs · Evidence Score: 43.6

Research Domains

Lovastatin has been studied across 24 research domains including 🔬 Oncology, ❤️ Cardiovascular, 😴 Sleep, 🔥 Metabolic, 🔬 Inflammation. The primary research focus is 🔬 Oncology with 29% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lovastatin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Melphalan
27 shared targets
Simvastatin
28 shared targets
Nisoldipine
34 shared targets
Flutamide
25 shared targets
Mometasone
23 shared targets
Oxymetholone
21 shared targets
Vitamin
27 shared targets
Aprepitant
21 shared targets
Ethinyl
27 shared targets
Azathioprine
20 shared targets
Loading evidence profile...

This evidence profile for Lovastatin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.